World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
116
Citations
53258
World Ranking
375
National Ranking
236

Medicine

D-Index
117
Citations
53700
World Ranking
4195
National Ranking
2298

Jeffrey N. Martin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jeffrey N. Martin sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 494 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jeffrey N. Martin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey N. Martin sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 116 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jeffrey N. Martin is affiliated with the University of California, San Francisco in the United States. Their work primarily focuses on medicine, with a substantial emphasis on infectious diseases, neurology, oncology, virology, and immunology.

The scientist's research covers various key topics such as:

  • Long-Term Effects of COVID-19
  • HIV/AIDS Research and Interventions
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Viral-associated cancers and disorders
  • HIV/AIDS drug development and treatment

Jeffrey N. Martin has contributed to several recent papers, including:

  • Tutorial on directed acyclic graphs, 2021, Journal of Clinical Epidemiology
  • Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, 2021, The Journal of Infectious Diseases
  • Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2, 2024, Nature Immunology
  • Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms, 2021, Cell Reports
  • Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy, 2020, JCI Insight

Frequent coauthors with whom Jeffrey N. Martin has collaborated include:

  • Steven G. Deeks
  • Michael J. Peluso
  • J. Daniel Kelly
  • Timothy J. Henrich
  • Rebecca Hoh

The scientist's work has been published repeatedly in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases
  • JCI Insight

Best Publications

  • Microbial translocation is a cause of systemic immune activation in chronic HIV infection

    Jason M. Brenchley;David A. Price;Timothy W. Schacker;Tedi E. Asher

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

    Hasina Samji;Angela Cescon;Robert S. Hogg;Robert S. Hogg;Sharada P. Modur

  • Effect of early versus deferred antiretroviral therapy for HIV on survival.

    Mari M. Kitahata;Stephen J. Gange;Alison G. Abraham;Barry Merriman

  • Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

    Steven G. Deeks;Christina M. R. Kitchen;Lea Liu;Hua Guo

  • Sexual Transmission and the Natural History of Human Herpesvirus 8 Infection

    Jeffrey N. Martin;Donald E. Ganem;Dennis H. Osmond;Kimberly A. Page-Shafer

  • Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1

    Maureen P. Martin;Ying Qi;Xiaojiang Gao;Eriko Yamada

  • T Cell Activation Is Associated with Lower CD4+ T Cell Gains in Human Immunodeficiency Virus-Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

    Peter W Hunt;Jeffrey N Martin;Elizabeth Sinclair;Barry Bredt

  • Relationship between T Cell Activation and CD4+ T Cell Count in HIV-Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy

    Peter W. Hunt;Jason Brenchley;Elizabeth Sinclair;Joseph M. McCune

  • Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection

    Wei Jiang;Michael M. Lederman;Peter Hunt;Scott F. Sieg

  • HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.

    Sergio Serrano-Villar;Talia Sainz;Sulggi A. Lee;Peter W. Hunt

  • Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.

    Priscilla Y. Hsue;Joan C. Lo;Arlana Franklin;Ann F. Bolger

  • Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.

    David Favre;Jeff Mold;Peter W. Hunt;Bittoo Kanwar

  • Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America

    Michael J. Silverberg;Bryan Lau;Amy C. Justice;Amy C. Justice;Eric Engels

  • Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection

    Peter W. Hunt;Elizabeth Sinclair;Benigno Rodriguez;Carey Shive

  • Incomplete Peripheral CD4+ Cell Count Restoration in HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment

    Colleen F. Kelley;Christina M. R. Kitchen;Peter W. Hunt;Benigno Rodriguez

  • Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.

    Priscilla Y Hsue;Peter W Hunt;Amanda Schnell;S Craig Kalapus

  • Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome

    Cynthia L. Monaco;David B. Gootenberg;Guoyan Zhao;Scott A. Handley

  • Decline in HIV infectivity following the introduction of highly active antiretroviral therapy.

    Travis C Porco;Jeffrey N Martin;Kimberly A Page-Shafer;Amber Cheng

  • Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.

    Benigno Rodríguez;Ajay K. Sethi;Vinay K. Cheruvu;Wilma Mackay

  • Suberoylanilide Hydroxamic Acid Reactivates HIV From Latently Infected Cells

    Xavier Contreras;Marc Schweneker;Ching-Shih Chen;Joseph M. McCune

Frequent Co-Authors

Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Peter W. Hunt
Peter W. Hunt University of California, San Francisco
David R. Bangsberg
David R. Bangsberg Simon Fraser University
Jessica E. Haberer
Jessica E. Haberer Harvard University
Joseph M. McCune
Joseph M. McCune University of California, San Francisco
Frederick Hecht
Frederick Hecht University of California, San Francisco
Alexander C. Tsai
Alexander C. Tsai Harvard University
Elizabeth Sinclair
Elizabeth Sinclair University of California, San Francisco
Mari M. Kitahata
Mari M. Kitahata University of Washington
Richard D. Moore
Richard D. Moore Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to a variety of online degree options and promising career paths. For those interested in healthcare roles closely linked to immunology, nursing programs offer a flexible route. The online RN programs for non nurses in Florida are an excellent choice for individuals switching careers or starting fresh in nursing.

Accelerated learning options can help fast-track your nursing credentials. The easiest accelerated nursing programs provide accessible pathways for professionals looking to advance quickly without sacrificing quality education.

For those interested in foundational nursing roles that can complement immunology knowledge, exploring the lpn programs easy to get into offers a practical entry point into patient care, often with shorter completion times and more flexible admission standards.

Advancing further into specialized practice, nurse practitioner degrees merge clinical expertise with leadership skills. Identifying which nurse practitioner program is easiest to enter can be crucial for career advancement, particularly for those interested in immunology-related patient care and research roles.

Best Scientists Citing Jeffrey N. Martin

Trending Scientists

Recently Published Articles